Dual-targeting CD44 and mucin by hyaluronic acid and 5TR1 aptamer for epirubicin delivery into cancer cells: Synthesis, characterization, in vitro and in vivo evaluation
One of the revolutionized cancer treatment is active targeting nanomedicines. This study aims to create a dual-targeted drug delivery system for Epirubicin (EPI) to cancer cells. Hyaluronic acid (HA) is the first targeting ligand, and 5TR1 aptamer (5TR1) is the second targeting ligand to guide the d...
Main Authors: | Zahra Jamshidi, Reza Dehghan, Mojgan Nejabat, Khalil Abnous, Seyed Mohammad Taghdisi, Farzin Hadizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024008648 |
Similar Items
-
Effect of Epirubicin Against Glioma Initiating Cells
by: Atsushi Nakajima, et al.
Published: (2020-11-01) -
Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer Therapy
by: Huma Khan, et al.
Published: (2021-08-01) -
Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting
by: Zhaoyi Li, et al.
Published: (2019-01-01) -
Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients
by: Fariselli C, et al.
Published: (2018-07-01) -
A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
by: Ching-Wen Liu, et al.
Published: (2016-06-01)